Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.

Biotechnology

Novocure

Novocure's headquarters in Saint Helier, Jersey

Asaf Danziger

Mukund Paravasthu

Wilco G.

Hilary Duckworth

Michael Puri

Brooke Huang

Jeff Bamonte

Moshe Giladi

Frank Leonard

Ashley Cordova

Wilco Groenhuysen

Barak Ben-Arye

Uri Weinberg

Yoram Palti

Martin J. Madden

William F. Doyle

David T. Hung

Kristin Stafford

Allyson J. Ocean

Timothy J. Scannell

William A. Vernon

Kinyip Gabriel Leung

Jeryl Hilleman

The Medical Device Support team at Novocure is dedicated to providing expert assistance and guidance for the use of Tumor Treating Fields technology in clinical settings. They ensure that healthcare professionals and patients receive comprehensive support, including training on device operations, troubleshooting technical issues, and maintaining compliance with regulatory standards. By facilitating a seamless experience for users, this team plays a crucial role in maximizing the therapeutic benefits of Novocure's innovative oncology solutions.

Medical Device Support

The Clinical Research & Development team at Novocure focuses on designing and executing clinical trials that evaluate the efficacy and safety of Tumor Treating Fields for various oncology indications. This multidisciplinary team collaborates with medical science liaisons, clinical scientists, and operational experts to ensure robust data collection and compliance with regulatory standards, ultimately contributing to the advancement of innovative cancer therapies. Their efforts aim to expand the therapeutic applications of Novocure's products and improve patient outcomes in aggressive cancer forms.

Clinical Research & Development

The Leadership Team at Novocure is responsible for steering the company's strategic direction and overseeing its operations to advance innovative cancer therapies. This diverse group of executives collaborates on research, product development, and commercialization efforts, ensuring a focus on patient impact while managing financial, regulatory, and operational challenges. Their collective expertise drives Novocure's mission to extend survival for patients with aggressive forms of cancer through Tumor Treating Fields technology.

Leadership Team

The Marketing and Communications team at Novocure is responsible for crafting and executing strategic marketing initiatives to promote the company's innovative Tumor Treating Fields therapy. They engage healthcare professionals and patients through digital marketing, global congresses, and targeted communications, while also managing key account relationships. The team's efforts aim to enhance brand awareness and support patient access to vital treatment options in oncology, particularly for glioblastoma and malignant pleural mesothelioma.

Marketing and Communications

Novocure

Org chart

Board & advisors

Teams

Medical Device Support

Clinical Research & Development

Leadership Team

Marketing and Communications

Offices

Novocure

Org chart

Board & advisors

Teams

Medical Device Support

Clinical Research & Development

Leadership Team

Marketing and Communications

Offices

Related companies